Rheumatoid Arthritis Clinical Trial
Official title:
B Cell Depletion Therapy in Rheumatoid Arthritis: An Analysis of Peripheral Blood T Cell Subsets
To study the effects of T cell in peripheral blood of patients with RA undergoing selective B cell depletion have not been studied. We analyze the B and T cell subsets in patients with active RA treated undergoing this form of treatment with rituximab.
- In this open labeled prospective study, we evaluate the therapeutic efficacy and
peripheral blood cellular response of rituximab in 10 patients with active RA despite
conventional DMARDs therapy.
- Patients are taking stable dose of methotrexate and at least 10mg folic acid per week
for at least 4 weeks. Rituximab is administrated as 1000mg intravenous infusion on day
1 and day 15. Premedication as standard prescription consists of methylprednisolone
100mg IV, Chlorpheniramine maleate(piriton 10mg IV and oral paracetamol 500mg to be
given 30 minutes before each infusion of rituximab. Oral prednisolone 60mg is tob e
given from day 1-6 after rituximab infusion and 30mg from day 7-13.
- In patients who relapses following the first cycle can be repeated with the second
cycle must fulfill the following conditions:
1. Patients must have responded clinically to the first infusion with improvement
2. Other disease modifying anti-rheumatic drugs (DMARDs) are not appropriate as
determined by the investigators, either they have been on them before or are
ineffective or due to side effects,
3. Patients have a disease activity score DSA>2.6
4. At least 24 weeks since the first infusion
5. Neutrophil count of >1.5 X 103/mcL
- The second infusion consists of rituximab 1000mg intravenous infusion on day 1 and day
15 as before and the same protocol of followed up every 4 weeks up to 52 weeks from the
day of the first infusion.14 Premedication as standard prescription (consists of
methylprednisolone 100mg IV, Chlorpheniramine maleate(piriton) 10mg IV and oral
paracetamol 500mg to be given 30 minutes before each infusion of rituximab.
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04226131 -
MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics
|
N/A | |
Completed |
NCT04171414 -
A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT02833350 -
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
|
Phase 2 | |
Completed |
NCT04255134 -
Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
|
Phase 4 | |
Recruiting |
NCT05615246 -
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
|
||
Completed |
NCT03248518 -
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
|
N/A | |
Completed |
NCT03514355 -
MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms
|
N/A | |
Recruiting |
NCT06005220 -
SBD121, a Synbiotic Medical Food for RA Management
|
N/A | |
Recruiting |
NCT05451615 -
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT05054920 -
Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT02037737 -
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
|
N/A | |
Recruiting |
NCT04079374 -
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
|
Phase 3 | |
Completed |
NCT02504268 -
Effects of Abatacept in Patients With Early Rheumatoid Arthritis
|
Phase 3 | |
Recruiting |
NCT05496855 -
Remote Care in People With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Recruiting |
NCT06103773 -
A Study of Single and Multiple Oral Doses of TollB-001
|
Phase 1 | |
Recruiting |
NCT06031415 -
Study of GS-0272 in Participants With Rheumatoid Arthritis
|
Phase 1 | |
Completed |
NCT05999266 -
The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
|
||
Recruiting |
NCT05302934 -
Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
|
||
Recruiting |
NCT04169100 -
Novel Form of Acquired Long QT Syndrome
|
Phase 4 |